Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions.
about
Pharmacology and Clinical Drug Candidates in Redox MedicineExperimental lupus is aggravated in mouse strains with impaired induction of neutrophil extracellular traps.Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.ROS in gastrointestinal inflammation: Rescue Or Sabotage?What has passed is prolog: new cellular and physiological roles of G6PD.Staphylococcus aureus, phagocyte NADPH oxidase and chronic granulomatous disease.Susceptibility to chronic inflammation: an update.Redox-sensitive signaling in inflammatory T cells and in autoimmune disease.
P2860
Q26785525-966F2EDC-C445-4106-99AF-59BB30206A42Q33703190-AB4E30A0-2296-45B8-BABA-3ED3F5B5A6F1Q34423996-BAC56CB7-F874-4F21-B6F6-EFA0C0400DCDQ38693962-9B0106E4-7878-4064-82A7-66941644F9F2Q38967640-2AB52343-F394-426C-B412-C8E33689907EQ39037945-00872D6B-E27E-400A-8180-8814B19814B5Q39107170-E028400A-622D-408F-9AAA-FBAD89B5410FQ52663131-32622275-0CB7-4D43-99E8-EA6DEB87C4AA
P2860
Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions.
@en
type
label
Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions.
@en
prefLabel
Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions.
@en
P2093
P356
P1476
Pharmacological Potential of NOX2 Agonists in Inflammatory Conditions
@en
P2093
Malin Hultqvist
Peter Olofsson
Rikard Holmdahl
P304
P356
10.1089/ARS.2013.5788
P577
2014-02-26T00:00:00Z